Lv1
46 积分 2024-08-21 加入
Metabolic Messengers: glucagon-like peptide 1
10小时前
待确认
The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial
1天前
已完结
Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction
4天前
已完结
Ablation of Prdm16 and beige fat identity causes vascular remodeling and elevated blood pressure
16天前
已完结
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
20天前
已完结
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
20天前
已完结
Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial
1个月前
已关闭
Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
1个月前
已完结
Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice
2个月前
已完结
Novel LC-MS/MS analysis of the GLP-1 analog semaglutide with its application to pharmacokinetics and brain distribution studies in rats
2个月前
已完结
皖公网安备34019202002308
